Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Massa

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|May 3, 2015
Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In VivoAndré Steven, Max Heiduk, Christian V Recktenwald, et al.
International Journal of Molecular Sciences|May 27, 2026
Inflammation and Colorectal Cancer Pathogenesis: Molecular, Immunological, and Environmental Features for Therapy Response and ResistancesBarbara Seliger, Rene Mantke, Norbert Naß, et al.
Oncoimmunology|May 9, 2022
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cellsKarthikeyan Subbarayan, Chiara Massa, Sandra Leisz, et al.
Oncotarget|October 22, 2015
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?Franziska Stehle, Sandra Leisz, Kristin Schulz, et al.
Clinical and Translational Medicine|July 8, 2022
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanomaChristoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Oncoimmunology|December 19, 2022
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapyChristoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.
Proteomics|May 20, 2011
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsBarbara Seliger, Sven P Dressler, Chiara Massa, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|May 3, 2015
Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In VivoAndré Steven, Max Heiduk, Christian V Recktenwald, et al.
International Journal of Molecular Sciences|May 27, 2026
Inflammation and Colorectal Cancer Pathogenesis: Molecular, Immunological, and Environmental Features for Therapy Response and ResistancesBarbara Seliger, Rene Mantke, Norbert Naß, et al.
Oncoimmunology|May 9, 2022
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cellsKarthikeyan Subbarayan, Chiara Massa, Sandra Leisz, et al.
Oncotarget|October 22, 2015
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?Franziska Stehle, Sandra Leisz, Kristin Schulz, et al.
Clinical and Translational Medicine|July 8, 2022
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanomaChristoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Oncoimmunology|December 19, 2022
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapyChristoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.
Proteomics|May 20, 2011
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsBarbara Seliger, Sven P Dressler, Chiara Massa, et al.
Pageof 5